Actrapid Hm 100Iu/ml Penfill 5 x 3 ml is a rapid-acting human insulin analogue for the treatment of diabetes mellitus in both children (above two years of age) and adults
In 2022, 1 in 8 individuals globally were living with obesity
Beyond glucose metabolism, Retatrutide Powder positively impacts lipid profiles
We work closely with authorities and regulatory bodies from around the world to continuously monitor the safety profile of our products. The EU patient leaflets for Wegovy, Ozempic and Rybelsus had been updated to include Naion, they added, but based on the totality of evidence, we concluded that the data did not suggest a reasonable possibility of a causal relationship between semaglutide and Naion and Novo Nordisk believes that the benefit-risk profile of semaglutide remains favourable.
The SURMOUNT-OSA trial data confirms this with hard numbers: significant reductions in apnea severity, improved sleep quality scores, and reduced daytime sleepiness
What the Research Shows About GLP-1s and Psoriasis Research on GLP-1s for psoriasis is still in its early stages, but some small studies have shown promise
